[Hormonal premedication in endometrium ablation--results of a prospective comparative study].

In: Zentralblatt fur Gynakologie · 1996 · vol. 118(5) , pp. 291–4 · PMID:8701626 · W2472954446
article OA: closed CC0 ⤵ 4 in-corpus citations
View on OpenAlex View on PubMed
AI-generated summary by claude@2026-06, 2026-06-07

Danazol and GnRH-analogon premedication improved endometrial ablation outcomes, resulting in thinner endometria, better coagulation, and higher amenorrhea rates compared to no pretreatment.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

In a prospective study in 40 patients the pretreatment for endometrial ablation with a gestagen (Orgametril 10 mg/die), danazol (600 mg/die) and an injection of a GnRH-analogon (Decapeptyl-Depot) was compared with a control group without pretreatment. The subjective estimation of the surgeon (endometrial thickness and depth of coagulation) showed a sufficient pretreatment in 90 % of all cases following danazol- and GnRH-analogon-pretreatment. In 90 % of the danazol- and GnRH-analogon pretreated group the histological findings showed also an atrophic or little proliferative endometrium. In a follow up of 6 months after endometrial ablation the highest amenorrhoea-rates were reached following danazol- and GnRH-analogon pretreatment. These two regimes should be used for the pretreatment for endometrial ablation.

My notes (saved in your browser only)

Condition tags

die_deep_infiltrating

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (4)

Cited by (4)

Source provenance

openalex
last seen: 2026-05-10T11:05:14.263564+00:00
License: CC0 · commercial use OK